MARKET

LOGC

Logicbio Therapeutics
LOGC
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-3.1413
12.39
3.294
68,232,857.31
ContextLogic To Acquire Gaylord Chemical At An EV Of $850M From Investment Funds Managed By Eagletree Capital
Benzinga · 08/05 11:20
Press Release: ContextLogic to Acquire gChem for -2-
Dow Jones · 08/05 11:03
Press Release: ContextLogic to Acquire gChem for $850 Million
Dow Jones · 08/05 11:03
*ContextLogic To Acquire GChem For $850 Million >LOGC
Dow Jones · 08/05 11:00
Press Release: ContextLogic Holdings Inc. Reports -2-
Dow Jones · 05/15 12:02
Press Release: ContextLogic Holdings Inc. Reports First-Quarter 2026 Financial Results
Dow Jones · 05/15 12:02
*ContextLogic Holdings 1Q EPS 33c >LOGC
Dow Jones · 05/15 12:00
Press Release: ContextLogic Appoints Paul S. Levy to Board of Directors
Dow Jones · 04/01 12:03
More

Webull offers Logicbio Therapeutics stock information, including NASDAQ: LOGC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LOGC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LOGC stock methods without spending real money on the virtual paper trading platform.